XML 18 R7.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
Common stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interest
Total
Beginning balance at Dec. 31, 2023 $ 22,000 $ 1,658,339,000 $ (929,472,000) $ (2,119,000) $ 6,877,000 $ 733,647,000
Beginning balance (in shares) at Dec. 31, 2023 223,026,966          
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock   231,000       231,000
Issuance of common stock (in shares) 236,089          
Shares withheld related to net share settlement   (304,000)       (304,000)
Stock-based compensation   2,629,000       2,629,000
Stock-based sales incentive charges   12,897,000       12,897,000
Net loss     (18,443,000)   (173,000) (18,616,000)
Other comprehensive income (loss)       (875,000)   (875,000)
Ending balance at Mar. 31, 2024 $ 22,000 1,673,792,000 (947,915,000) (2,994,000) 6,704,000 729,609,000
Ending balance (in shares) at Mar. 31, 2024 223,263,055          
Beginning balance at Dec. 31, 2023 $ 22,000 1,658,339,000 (929,472,000) (2,119,000) 6,877,000 733,647,000
Beginning balance (in shares) at Dec. 31, 2023 223,026,966          
Increase (Decrease) in Stockholders' Equity            
Net loss         (347,000) (35,083,000)
Other comprehensive income (loss)         0 (1,416,000)
Ending balance at Jun. 30, 2024 $ 22,000 1,690,762,000 (964,208,000) (3,535,000) 6,530,000 729,571,000
Ending balance (in shares) at Jun. 30, 2024 223,332,502          
Beginning balance at Mar. 31, 2024 $ 22,000 1,673,792,000 (947,915,000) (2,994,000) 6,704,000 729,609,000
Beginning balance (in shares) at Mar. 31, 2024 223,263,055          
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock (in shares) 69,447          
Stock-based compensation   2,862,000       2,862,000
Stock-based sales incentive charges   14,079,000       14,079,000
Net loss     (16,293,000)   (174,000) (16,467,000)
Other comprehensive income (loss)       (541,000) 0 (541,000)
Issuance of common stock warrants   29,000       29,000
Ending balance at Jun. 30, 2024 $ 22,000 1,690,762,000 (964,208,000) (3,535,000) 6,530,000 729,571,000
Ending balance (in shares) at Jun. 30, 2024 223,332,502          
Beginning balance at Dec. 31, 2024 $ 22,000 1,730,090,000 (1,012,542,000) (4,297,000) 6,258,000 $ 719,531,000
Beginning balance (in shares) at Dec. 31, 2024 223,456,994         223,456,994
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock   222,000       $ 222,000
Issuance of common stock (in shares) 506,632          
Repurchase of common stock   (391,000)       (391,000)
Repurchase of common stock (in shares) (227,495)          
Shares withheld related to net share settlement   (498,000)       (498,000)
Stock-based compensation   1,777,000       1,777,000
Stock-based sales incentive charges   17,338,000       17,338,000
Net loss     (134,967,000)   (64,000) (135,031,000)
Other comprehensive income (loss)       (52,000)   (52,000)
Issuance of common stock warrants   2,000       2,000
Ending balance at Mar. 31, 2025 $ 22,000 1,748,540,000 (1,147,509,000) (4,349,000) 6,194,000 602,898,000
Ending balance (in shares) at Mar. 31, 2025 223,736,131          
Beginning balance at Dec. 31, 2024 $ 22,000 1,730,090,000 (1,012,542,000) (4,297,000) 6,258,000 $ 719,531,000
Beginning balance (in shares) at Dec. 31, 2024 223,456,994         223,456,994
Increase (Decrease) in Stockholders' Equity            
Net loss         (232,000) $ (155,439,000)
Other comprehensive income (loss)         0 2,032,000
Ending balance at Jun. 30, 2025 $ 22,000 1,760,813,000 (1,167,749,000) (2,265,000) 6,026,000 $ 596,847,000
Ending balance (in shares) at Jun. 30, 2025 219,187,208         219,187,208
Beginning balance at Mar. 31, 2025 $ 22,000 1,748,540,000 (1,147,509,000) (4,349,000) 6,194,000 $ 602,898,000
Beginning balance (in shares) at Mar. 31, 2025 223,736,131          
Increase (Decrease) in Stockholders' Equity            
Issuance of common stock (in shares) 137,400          
Repurchase of common stock   (7,547,000)       (7,547,000)
Repurchase of common stock (in shares) (4,686,323)          
Stock-based compensation   2,403,000       2,403,000
Stock-based sales incentive charges   17,396,000       17,396,000
Net loss     (20,240,000)   (168,000) (20,408,000)
Other comprehensive income (loss)       2,084,000 0 2,084,000
Issuance of common stock warrants   21,000       21,000
Ending balance at Jun. 30, 2025 $ 22,000 $ 1,760,813,000 $ (1,167,749,000) $ (2,265,000) $ 6,026,000 $ 596,847,000
Ending balance (in shares) at Jun. 30, 2025 219,187,208         219,187,208